Strategy

Aug 01, 2005
Pharmaceutical Executive
Eyes in the Back of Your Head
Aug 01, 2005
Pharmaceutical Executive
Leadership evolves from the dynamic of particular situations. Without Adolf Hitler, Winston Churchill may have been remembered as a quirky backbencher.
Aug 01, 2005
Pharmaceutical Executive
Western pharma companies call on only China's largest hospitals in the biggest cities. By some estimates, this amounts to only 20,000 doctors.
Aug 01, 2005
Pharmaceutical Executive
BMS' use of investigational toxicology puts it in good stead with FDA, which, under its Critical Path initiative, is pushing for more complete toxicology packages.
Jul 01, 2005
Pharmaceutical Executive
Accept distortions and untruths. Don't try to undo them. The point is not to win an argument; your critics' views are legitimate, irreversible realities. It's time to give the public something new to think about.
Jul 01, 2005
Pharmaceutical Executive
Without common reporting standards in place, researchers have little incentive to share data with scientists elsewhere in the company. When researchers don't sharedata on a regular basis, they can begin to feel proprietary about their work—and even less inclined to disclose their results.
Jul 01, 2005
Pharmaceutical Executive
Without common reporting standards in place, researchers have little incentive to share data with scientists elsewhere in the company. When researchers don't sharedata on a regular basis, they can begin to feel proprietary about their work—and even less inclined to disclose their results.
Jul 01, 2005
Pharmaceutical Executive
We all remember the Greek myth about old King Sisyphus. In life, he was a trickster, but the gods got the last laugh in the afterlife by making it his fate to push a huge boulder up a mountain only to see it roll down just before reaching the summit—again and again for all eternity.
Jul 01, 2005
Pharmaceutical Executive
By Pharmaceutical Executive Editors
These are demanding times for pharmaceutical marketers.
Jun 01, 2005
Pharmaceutical Executive
By Pharmaceutical Executive Editors
A small company with an ambitious goal—to prevent infections instead of treating them after the fact—is about to start a revolution.
native1_300x100
lorem ipsum